NASDAQ:NERV - Nasdaq - US6033802058 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 41.18M | |||
Operating Expenses | 24.50M | 23.12M | 25.23M | 45.37M | 39.33M | |||
Research and Development | 14.64M | 12.71M | 14.65M | 32.04M | 22.04M | |||
Selling, General, and Administrative Expenses | 9.86M | 10.41M | 10.58M | 13.33M | 17.29M | |||
Operating Income | -24.50M | -23.12M | -25.23M | -45.37M | 1.85M | |||
Interest Income/Expense | 1.36M | 1.40M | 530.00K | -20.00K | 90.00K | |||
Other Income/Expense | 19.83M | -8.28M | -7.41M | -6.33M | N/A | |||
Income Before Taxes | -3.31M | -30.01M | -32.11M | -51.71M | 1.94M | |||
Income Tax | N/A | N/A | 0.00 | -1.80M | 0.00 | |||
Net Income | -3.31M | -30.01M | -32.11M | -49.91M | 1.94M | |||
EBITDA | -24.47M | -23.09M | -25.22M | N/A | 1.87M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.44 | -4.61 | -6.01 | -9.35 | 0.38 | |||
Non GAAP EPS | -4.15 | -4.85 | -6.02 | -9.20 | 0.40 | |||
Statistics | ||||||||
Profit Margin | N/A | N/A | N/A | N/A | 4.71% | |||
Operating Profit Margin | N/A | N/A | N/A | N/A | 4.49% |
All data in USD